Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
S1P1 Receptor Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist.
IL-17 induces MIP-1α expression in primary mouse astrocytes via TRPC channel.
Combination of robot-assisted and conventional body-weight-supported treadmill training improves gait in persons with multiple sclerosis: a pilot study.
Paroxysmal ataxia and dysarthria in multiple sclerosis.
A standardized motor imagery introduction program (MIIP) for neuro-rehabilitation: development and evaluation.
Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies.
Electrophysiological features of POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
Multiple sclerosis: Linking disability and spinal cord imaging outcomes in MS.
Alemtuzumab in multiple sclerosis: latest evidence and clinical prospects.
Age and the role of restricted activities in adjustment to disability related pain.
How much sunlight is enough?
MRI unsampling using feature-based non-local means approach.
The meninges: new therapeutic targets for multiple sclerosis.
Disability Identity Predicts Lower Anxiety and Depression in Multiple Sclerosis.
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.
Inflammation and oxidative stress induced by cigarette smoke in Lewis rat brains.
Personalized medicine in multiple sclerosis: hope or reality?
Benefits of whole-body vibration with an oscillating platform for people with multiple sclerosis: a systematic review.
Nature plus nurture: the triggering of multiple sclerosis.
The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.
Vitamin B(12) in neurology and ageing; Clinical and genetic aspects.
Aurintricarboxylic Acid Ameliorates Experimental Autoimmune Encephalomyelitis by Blocking Chemokine-Mediated Pathogenic Cell Migration and Infiltration.
The myelin mutants as models to study myelin repair in the leukodystrophies.
A salty taste to autoimmunity.
Notch Signaling Regulates T Cell Accumulation and Function in the Central Nervous System during Experimental Autoimmune Encephalomyelitis.
Pages
« first
‹ previous
…
307
308
309
310
311
312
313
314
315
…
next ›
last »